Scott Hutton Email and Phone Number
Scott Hutton's Location
Louisville, Colorado, United States, United States
Scott Hutton's Contact Details
Scott Hutton work email
- Valid
- Valid
- Valid
- Valid
Scott Hutton personal email
- Valid
Scott Hutton phone numbers
About Scott Hutton
Scott Hutton is President, Chief Executive Officer, and Director of Biodesix (NASDAQ: BDSX) in Louisville, CO, where his personal leadership philosophy emphasizes helping people, giving back, and positively impacting/improving people’s health and lives. Under his leadership, Biodesix has grown into a leading diagnostics company with a great company culture most recently recognized by Inc. Magazine as a Best Workplace for 2024. In 2020, during the global pandemic, Hutton led the Biodesix team through an October initial public offering (IPO).Hutton is an accomplished, inspirational, and strategic leader with 25+ years of experience in the diagnostic and medical device industries. He has a proven track record of successfully recruiting, developing, and leading high performance teams credited with 50+ product launches positively impacting tens of millions of patients globally. He joined Biodesix from Spectranetics (NASDAQ: SPNC), now part of Royal Philips (NYSE: PHG), where he served, until acquisition, as Senior Vice President and General Manager of the Vascular Intervention division. Prior to joining Spectranetics, Hutton spent 16+ years at Medtronic (NYSE: MDT) where he most recently led the Neurosurgery business unit as Vice President and General Manager. Hutton is a Purdue University grad, having earned a Bachelor of Arts degree from the College of Health and Human Sciences, Department of Health and Kinesiology, in 1995. Hutton was an active member of Delta Delta Chapter of Sigma Chi Fraternity. Hutton currently serves on the Coalition for 21st Century Medicine (C21) Board of Directors and Eximis Surgical Board of Directors. He has held many advisory, director and observer positions, including Colorado BioScience Association (CBSA) Board of Directors, Aqueduct Critical Care Board of Directors Observer, and Visualase Board of Directors Observer.Hutton’s achievements/recognition include being named a Top 25 Biotech Executive of 2024 by the Healthcare Technology Report, receiving the 2022 Purdue University Health and Kinesiology Distinctive Service Award, receiving the 2022 Purdue University Health and Human Sciences Distinguished Alumni Award, being named a Top 25 Biotech CEO of 2022 by the Healthcare Technology Report, being named a 2021 Purdue University Old Master, receiving the 2021 Significant Sig Award from Sigma Chi Fraternity, being named a Top 25 Biotech CEO of 2021 by the Healthcare Technology Report, being named 2020 CEO of the Year-USA by CEO Monthly Magazine, and receiving the 2011 Medtronic Wallin Leadership Award.
Scott Hutton's Current Company Details
Scott Hutton Work Experience Details
-
President & Chief Executive OfficerBiodesix, Inc. Jan 2020 - PresentLouisville, Colorado, UsBusiness growth highlights1H 2024• $32.7 million in total Revenue• 56% total Revenue growth over 1H 2023• 46% Lung Diagnostic test volume growth over 1H 2023• 51% Lung Diagnostic revenue growth over 1H 2023• 189% Biopharma Services revenue growth over 1H 2023• 79% Gross Profit Margin• 44% improvement in Adj EBITDA over 1H 20232023• Total Revenue = $49.1 million (49% growth over 2022)• 65% Lung Diagnostic test volume growth over 2022• 55% Lung Diagnostic revenue growth over 2022Company and Team• 5 Medicare covered tests in Lung Disease Diagnostics• >650,000 tests results delivered all-time• Initial Public Offering (IPO) in October 2020Advancements in Science, Research, and IP• >300 publications, presentations, and abstracts including the ORACLE clinical utility study (7/23)• >65 Biopharmaceutical companies partnering for research and development services• >8 technology platforms for research use• ~122 issued patents and 22 trademarks covering the US and certain global territories• Multi-omic (genomic + proteomic) offering for both clinical and research use• Major partnerships and agreements with Academic researchers, Research Consortiums, Technology providers, and Software developersCulture & Leadership achievements• Dedicated to maintaining and improving diversity of our teammates – team comprised of >50% women• Committed to building a workplace culture that is engaging and fulfilling for all team membersAwards & Recognition• Inc. Magazine’s 2024 Best Workplaces• Newsweek Top Digital Healthcare Companies of 2024• Healthcare Technology Report’s Power 500 Healthcare Technology Companies of 2023• Healthcare Technology Report’s Top 100 Healthcare Technology Companies of 2022• Life Sciences Review Magazine’s Top Proteomic Solutions Company of 2022
-
DirectorBiodesix, Inc. Jan 2020 - PresentLouisville, Colorado, Us
-
Chief Operating Officer, Ceo-In-WaitingBiodesix, Inc. Mar 2018 - Dec 2019Louisville, Colorado, UsReported directly to the Founder & CEO and interacted with the Biodesix Board of Directors, Observers, Investors, Bankers and Analyst. Recruited and hired to be the CEO-in-waiting. Responsible for leadership of the Biodesix business and teams (Boulder, CO, USA; De Soto, KS, USA; Seattle, WA, USA; Steamboat Springs, CO, USA) consisting of 150 teammates. • Launched the Nodify XL2 "Rule-Out" Proteomic Test in September 2019.• Led strategic and transformational shift from lung cancer treatment/therapeutic guidance focus to broader lung cancer continuum of care (to include diagnosis) focus.• Colorado BioScience Association (CBSA) Company of the Year winner in 2019 and finalist in 2018.• Acquired and integrated two businesses, teams, labs, and tests/products. July 2018, Seattle, WA–based Integrated Diagnostics, Inc. (Indi) and the Xpresys Lung 2 (Nodify XL2) proteomic test which offers a noninvasive means of ruling out cancer for patients with suspicious lung nodules; and October 2019, De Soto, KS–based Oncimmune USA (ONC) and the EarlyCDT-Lung (Nodify CDT) proteomic test which offers a noninvasive means of identifying malignant lung nodules.• Proprietary Blood Specimen Collection Device (BCD) US Patent secured in 2019 and NY State-Clinical Lab Evaluation Program (CLEP) approval received in 2018.• Enrolled 3,000+ patients into the VeriStrat INSIGHT observational study• Appointed Co-Chief Medical Officers (CMO), Dr. James Jett and Dr. Steven Springmeyer
-
Director And SecretaryThe Coalition For 21St Century Medicine May 2023 - PresentWashington, Dc, Us -
DirectorEximis Surgical Feb 2018 - Present
-
Senior Vice President & General Manager, Ceo-In-WaitingSpectranetics Jan 2017 - Dec 2017Colorado Springs, Colorado, UsExecutive Officer reporting directly to the President & CEO and interacting with the SPNC Board of Directors, Investors and Analyst. Recruited and hired to be the CEO-in-waiting. Responsible for leadership of the $181.6M (2016) Vascular Intervention (VI) business and teams (Broomfield, CO, USA; Colorado Springs, CO, USA; Fremont, CA, USA; Maple Grove, MN, USA) consisting of 750+ teammates with an expense budget of $84.2M. • Achieved >10% quarterly growth (11% (Q1), and 11% (Q2)) over prior year• Generated $46.4M (Q1), $51.0M (Q2)• Achieved 24% Net Promoter Score (NPS) for FY17 vs. 18% prior year (FY16)• Achieved 82% Willingness to Recommend (WTR) for FY17 vs. 65% prior year (FY16)• Achieved >20% Vitality Index• Participated in the sale of Spectranetics Corp to Royal Philips Image Guided Therapy (IGT) Business Group for $2.2B. Led post-acquisition integration on the Spectranetics Vascular Interventions (VI) side.• Launched two products (Stellarex Drug-Coated 0.035” OTW Angioplasty Balloon (DCB) in July, Turbo-Power 6Fr Laser Atherectomy Catheter in February)• ColoradoBiz Magazine “Top Company” in Manufacturing (2017), BrainShark Sharkie Sales Enablement Program of the Year (2017)• Fourteen member VI leadership team (eight direct reports & six dotted line reports) located in four locations -
Vice President & General Manager, Brain Therapies - NeurosurgeryMedtronic Apr 2016 - Jan 2017Minneapolis, Mn, UsReported directly to the President of the Brain Therapies division. Responsible for the transition from Surgical Technologies into the newly created Brain Therapies division. Responsible for the leadership of four different businesses and sites (Midas Rex in Ft. Worth, TX; PS Medical in Goleta, CA; BreakAway Imaging in Littleton, MA; Surgical Navigation Technologies in Louisville, CO) with 2,400+ employees focused on transforming the way the world treats patients with brain and spine disorders. Created and implemented the unified and comprehensive Neurosurgery vision, 5-year transformational strategy and org structure.Achieved 9.9% (FY17 YTD) annual revenue growth.Positioned to generate >$1.0B in annual revenue in FY17.Exceed budget two out of two quartersResponsible for 2 surgical robotics business development transactions (1 lead share/distribution agreement for Spine and 1 structured acquisition for Cranial).Launched four products (StrataMR, Cranial Perforator, Navigated Drill, MazorX Spine Robot) with StealthStation S8 awaiting FDA approval.Led strategic and transformational shift from surgical instruments, enabling technologies and services to therapies and integrated procedural solutions (imaging + surgical navigation + robotics + lasers + powered instruments + monitoring).Initiated STELAR (STEreotactic Laser Ablation Registry) Neuro Tumor registry for indication expansion of Visualase MRI-Guided Laser Ablation Technology.Thirteen member leadership team (seven direct reports and six dotted line reports) located in three locations. -
Vice President & General Manager, Surgical Technologies - NeurosurgeryMedtronic Apr 2012 - Apr 2016Minneapolis, Mn, UsReported directly to President of Surgical Technologies division. Responsible for integration & leadership of six different businesses, teams, & sites (Midas Rex in Ft. Worth, TX, USA; PS Medical in Goleta, CA, USA; Visualase in Houston, TX, USA; BreakAway Imaging in Littleton, MA, USA, Surgical Navigation Technologies in Louisville, CO, USA; Odin Medical in Yokneam, Israel) w 2,400+ employees to create the new Neurosurgery business unit focused on transforming the way the world treats patients w brain & spine disorders. Created & implemented the unified & comprehensive Neurosurgery vision, 5-year transformational strategy & org structure.Achieved >6.5% annual revenue growth each fiscal year (12.8% (FY13), 9.3% (FY14), 6.7% (FY15), 9.2% (FY16)Generated $773.1M (FY13), $844.5M (FY14), $889.0M (FY15), and $950.6M (FY16) in annual revenueAchieved 41% (FY13), 57% (FY14), 57% (FY15), and 57% (FY16) Net Promoter Score (NPS)Exceed budget seventeen out of twenty quartersResponsible for 1 acquisition, 3 equity investments, 2 license agreements & 4 distribution agreementsLaunched twelve products (Cranial 2.25/2.2.7/3.0 SW, Spine 2.1 SW, O-arm Cranial EC3D SW, Navigated Osteotomes & Interbody, SonoNav SW, MicroSaws, NIM Eclipse GUI, O-arm O2, ClearView, Visualase Ti Bone Anchor & Enhanced Visualization).Led strategic & transformational shift from surgical instruments, enabling technologies & services to therapies & integrated procedural solutions (imaging+surgical navigation+robotics+lasers+powered instruments+monitoring).Medtronic Neurosurgery Strive Award recipient.CBSA Company of the Year finalist in 2013 & Chairman's Award in 2015.Initiated SLATE (Stereotactic Laser Ablation for Temporal Lobe Epilepsy) IDE study for indication expansion of Visualase MRI-Guided Laser Ablation Technology.Executive sponsor for Medtronic Emerging Leader Program (4/12-4/15).Thirteen member leadership team (seven direct reports and six dotted line reports) located in three locations.
-
Vice President & Business Leader (Interim Gm), Surgical Technologies - NavigationMedtronic Jul 2011 - Apr 2012Minneapolis, Mn, UsReported directly to the President of the Surgical Technologies division. Responsible for leading and managing the Navigation leadership team, strategic plan implementation and tactics for the remainder of FY12 while maintaining prior Global Marketing responsibilities.Achieved 14.0% annual revenue growth and generated $269.2M in FY12 (exceed plan by $15.7M)Achieved 46% Net Promoter Score (NPS) for FY12.Launched four products (Cranial 2.2 SW, AxiEM-only StealthStation S7, Navigation Optical Spheres, FrameLink 5.4 SW).Twelve member leadership team (six direct reports and six dotted line reports) all located in one location.
-
Sr. Director Of Global Marketing, Surgical Navigation And Intra-Operative ImagingMedtronic Dec 2008 - Jul 2011Minneapolis, Mn, UsReported directly to the Vice President and General Manager of the Navigation business unit. Responsible for all Global Surgical Navigation and Intra-Operative Imaging technologies and services. Led a team of thrity-one marketing professionals located in two locations. Restructured and reorganized the team to better meet the global commercial marketing needs of the business and team.Achieved >11.0% annual revenue growth each fiscal year (18.4% (FY09), 11.0% (FY10), 14.6% (FY11))Achieved 26% Net Promoter Score (NPS) for FY11 (initial measurement).Launched twelve products (Cranial 2.0/2.1 SW, Spine 1.7/2.0 SW, Ortho Hip/Knee SW, PoleStar N30, Universal NavLock, Navigated Pak Needle, StealthViz SW, Skull Base SW, O-arm 3.1 SW).Medtronic Wallin Leadership Award recipient (6/11) for strong and effective leadership and commitment to developing talent and future leaders.Introduced and implemented Customer Satisfaction (CSAT) and Net Promoter Score (NPS) measurements and created a dedicated Survey facilitator position.Created a dedicated Services Marketing role.Crafted and implemented a social media marketing strategy and campaign.
-
Director Of Business Development, Spinal & BiologicsMedtronic Jun 2007 - Dec 2008Minneapolis, Mn, UsReported directly to the Vice President of Finance. Responsible for the assessment of business strategies and the evaluation of inorganic business development opportunities including: technology licenses, consulting and development arrangements, distribution agreements, mergers and acquisitions, strategic alliances, joint ventures and minority investments for the Medtronic Spinal and Biologics division.Completed fourteen intellectual property transactions, three development/license/supply agreements, two equity investments, one acquisition and one divestiture.
-
Group Director Of Marketing, SpinalMedtronic Apr 2006 - Jun 2007Minneapolis, Mn, UsReported directly to the Vice President and General Manager of the Spinal division. Responsible for all Intradiscal and Tumor/Trauma products. Led a team of twelve marketing professionals.Generated $366.6M in annual revenue with 5.2% growth in FY07 (first $100M+ Interbody device - Capstone).Launched four products (Crescent VBS, Scissor Jack, Posterior Microscope Instrument Set, Vantage Plate).Submitted patent application to the USPTO - Implants and Related Devices for Monitoring Bony Fusion, filed 11/06; published 7/08 (#20080177387).
-
Director Of Marketing, SpinalMedtronic Apr 2004 - Apr 2006Minneapolis, Mn, UsReported directly to the Group Director of the Spinal division Extradiscal product portfolio. Responsible for all TSRH brand products. Led a team of five marketing professionals.Generated $121.5M in annual revenue in FY05 and $115.6M in annual revenue in FY06.Launched two products (TSRH 3D plus MPA, TSRH SiLo).
-
Sr. Product Manager, SpinalMedtronic Apr 2002 - Apr 2004Minneapolis, Mn, UsReported directly to the Director of the Spinal division Thoracolumbar product portfolio. Responsible for Trauma products (FY04) and Deformity products (FY03). Led team of three marketing professionals.Generated $58.8M with 68.6% growth (FY03) and $46.3M with 52.0% growth (FY04).Launched three products (X10 Crosslink Plate, Colorado II Sacral Plate, MSD Wire) in FY03 and one product (Vantage Plate) in FY04.
-
Product Manager, SpinalMedtronic Dec 2000 - Apr 2002Minneapolis, Mn, UsReported directly to the Director of the Spinal division Thoracolumbar TSRH brand portfolio of products.Generated $69.9M in annual revenue with 9.8% growth in FY02.
-
Board Of DirectorsAqueduct Critical Care, Inc. Sep 2014 - Jan 2017
-
Board Of DirectorsVisualase, Inc. Oct 2012 - Jul 2014Houston, Tx, Us -
Board Of DirectorsColorado Bioscience Association Apr 2011 - Apr 2013Denver, Us -
Sales RepresentativeLapoint & Associates, Inc. Jan 1999 - Dec 2000Distributor for DePuy Orthopaedics, Biomet Orthopedics, Stackhouse and Orthosonics.
-
Sales ManagerMega Manufacturing, Inc. Jun 1996 - Jan 1999FY97 - National Sales Manager of the YearFY97 - First Sales Manager to exceed $3M in annual sales with 35% growth
-
Sales ManagerUnited Industries May 1995 - Jun 1996Beloit, Wi, Us -
Research AssistantMethodist Sports Medicine Center May 1994 - Aug 1994
Scott Hutton Skills
Medical Devices
Leadership
Product Launch
Cross Functional Team Leadership
Marketing
Executive Management
Market Development
Strategy
Inspiring Leadership
Sales
Team Leadership
Strategic Planning
Neurosurgery
Capital Equipment
Team Motivation
Business Development
Public Speaking
Marketing Strategy
Orthopedic
Commercialization
Global Marketing
Team Building
Spine
Product Management
Healthcare
New Business Development
Motivational Speaking
Product Development
Mentoring
Sales Management
Product Marketing
Competitive Analysis
Executive Coaching
Sales Operations
Fda
Coaching
Board Of Directors
Operating Room
Start Ups
Biotechnology
Investor Relations
Service
Personalized Medicine
Medical Diagnostics
Molecular Diagnostics
Laparoscopic Surgery
Immunotherapy
Scott Hutton Education Details
-
Purdue UniversityDepartment Of Health & Kinesiology
Frequently Asked Questions about Scott Hutton
What company does Scott Hutton work for?
Scott Hutton works for Biodesix, Inc.
What is Scott Hutton's role at the current company?
Scott Hutton's current role is President, Chief Executive Officer & Director at Biodesix, Inc..
What is Scott Hutton's email address?
Scott Hutton's email address is co****@****hia.net
What is Scott Hutton's direct phone number?
Scott Hutton's direct phone number is +172089*****
What schools did Scott Hutton attend?
Scott Hutton attended Purdue University.
What skills is Scott Hutton known for?
Scott Hutton has skills like Medical Devices, Leadership, Product Launch, Cross Functional Team Leadership, Marketing, Executive Management, Market Development, Strategy, Inspiring Leadership, Sales, Team Leadership, Strategic Planning.
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial